Lung Cancer Screening by Low-Dose CT Scan: Baseline Results of a French Prospective Study

Lung cancer mortality has been found to decrease significantly with low-dose (LD) computed tomographic (CT) screening among current or former smokers. However, such a screening program is not implemented in France. This study assessed the feasibility of a lung cancer screening program using LD CT sc...

Full description

Saved in:
Bibliographic Details
Published inClinical lung cancer Vol. 21; no. 2; pp. 145 - 152
Main Authors Leleu, Olivier, Basille, Damien, Auquier, Marianne, Clarot, Caroline, Hoguet, Estelle, Pétigny, Valérie, Addi, Amale Aït, Milleron, Bernard, Chauffert, Bruno, Berna, Pascal, Jounieaux, Vincent
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2020
Elsevier
Subjects
Online AccessGet full text
ISSN1525-7304
1938-0690
1938-0690
DOI10.1016/j.cllc.2019.10.014

Cover

Abstract Lung cancer mortality has been found to decrease significantly with low-dose (LD) computed tomographic (CT) screening among current or former smokers. However, such a screening program is not implemented in France. This study assessed the feasibility of a lung cancer screening program using LD CT scan in a French administrative territory. We report here the results of the first screening round. DEP KP80 was a single-arm prospective study initiated in May 2016. Participants aged 55 to 74 years, current or former smokers of ≥ 30 pack-years, were recruited. An annual LD CT scan was scheduled. Our algorithms considered nodules < 5 mm as negative findings and nodules > 10 mm as positive; for intermediate nodules between 5 and 10 mm, 3-month CT scan with doubling time measurement was recommended. All general practitioners, pulmonologists, and radiologists from the Somme department were solicited to participate. Subjects were selected by general practitioners or pulmonologists who checked the inclusion criteria and prescribed the CT scan. Over a 2.5-year period, 1307 subjects were recruited. Screening was negative in 733 cases (77.2%), positive in 54 (5.7%), and indeterminate in 162 (17.1%). After the 3-month scans, 57 subjects screened positive: 26 patients exhibited 31 lung cancers (67.7% of stage 0 to I), of whom 76.9% underwent surgical resection, and 29 had no cancer (false-positive rate = 3.1%). The prevalence of lung cancer was 2.7%. This study demonstrated the feasibility of organized lung cancer screening using LD CT scan within a real-life context in the general population. Two large randomized controlled trials (NLST, NELSON) revealed a significant decrease in lung cancer mortality with low-dose computed tomographic screening, but its implementation is still debatable. The aim of our prospective multicenter study was to assess the implementation of a lung cancer screening program in a real-life setting. Our study demonstrated the feasibility of this screening program in the general population.
AbstractList Lung cancer mortality has been found to decrease significantly with low-dose (LD) computed tomographic (CT) screening among current or former smokers. However, such a screening program is not implemented in France. This study assessed the feasibility of a lung cancer screening program using LD CT scan in a French administrative territory. We report here the results of the first screening round. DEP KP80 was a single-arm prospective study initiated in May 2016. Participants aged 55 to 74 years, current or former smokers of ≥ 30 pack-years, were recruited. An annual LD CT scan was scheduled. Our algorithms considered nodules < 5 mm as negative findings and nodules > 10 mm as positive; for intermediate nodules between 5 and 10 mm, 3-month CT scan with doubling time measurement was recommended. All general practitioners, pulmonologists, and radiologists from the Somme department were solicited to participate. Subjects were selected by general practitioners or pulmonologists who checked the inclusion criteria and prescribed the CT scan. Over a 2.5-year period, 1307 subjects were recruited. Screening was negative in 733 cases (77.2%), positive in 54 (5.7%), and indeterminate in 162 (17.1%). After the 3-month scans, 57 subjects screened positive: 26 patients exhibited 31 lung cancers (67.7% of stage 0 to I), of whom 76.9% underwent surgical resection, and 29 had no cancer (false-positive rate = 3.1%). The prevalence of lung cancer was 2.7%. This study demonstrated the feasibility of organized lung cancer screening using LD CT scan within a real-life context in the general population. Two large randomized controlled trials (NLST, NELSON) revealed a significant decrease in lung cancer mortality with low-dose computed tomographic screening, but its implementation is still debatable. The aim of our prospective multicenter study was to assess the implementation of a lung cancer screening program in a real-life setting. Our study demonstrated the feasibility of this screening program in the general population.
Two large randomized controlled trials (NLST, NELSON) revealed a significant decrease in lung cancer mortality with low-dose computed tomographic screening, but its implementation is still debatable. The aim of our prospective multicenter study was to assess the implementation of a lung cancer screening program in a real-life setting. Our study demonstrated the feasibility of this screening program in the general population. Background: Lung cancer mortality has been found to decrease significantly with low-dose (LD) computed tomographic (CT) screening among current or former smokers. However, such a screening program is not implemented in France. This study assessed the feasibility of a lung cancer screening program using LD CT scan in a French administrative territory. We report here the results of the first screening round. Patients and Methods: DEP KP80 was a single-arm prospective study initiated in May 2016. Participants aged 55 to 74 years, current or former smokers of >= 30 pack-years, were recruited. An annual LD CT scan was scheduled. Our algorithms considered nodules < 5 mm as negative findings and nodules > 10 mm as positive; for intermediate nodules between 5 and 10 mm, 3-month CT scan with doubling time measurement was recommended. All general practitioners, pulmonologists, and radiologists from the Somme department were solicited to participate. Subjects were selected by general practitioners or pulmonologists who checked the inclusion criteria and prescribed the CT scan. Results: Over a 2.5-year period, 1307 subjects were recruited. Screening was negative in 733 cases (77.2%), positive in 54 (5.7%), and indeterminate in 162 (17.1%). After the 3-month scans, 57 subjects screened positive: 26 patients exhibited 31 lung cancers (67.7% of stage 0 to I), of whom 76.9% underwent surgical resection, and 29 had no cancer (false-positive rate = 3.1%). The prevalence of lung cancer was 2.7%. Conclusion: This study demonstrated the feasibility of organized lung cancer screening using LD CT scan within a real-life context in the general population.
Lung cancer mortality has been found to decrease significantly with low-dose (LD) computed tomographic (CT) screening among current or former smokers. However, such a screening program is not implemented in France. This study assessed the feasibility of a lung cancer screening program using LD CT scan in a French administrative territory. We report here the results of the first screening round.BACKGROUNDLung cancer mortality has been found to decrease significantly with low-dose (LD) computed tomographic (CT) screening among current or former smokers. However, such a screening program is not implemented in France. This study assessed the feasibility of a lung cancer screening program using LD CT scan in a French administrative territory. We report here the results of the first screening round.DEP KP80 was a single-arm prospective study initiated in May 2016. Participants aged 55 to 74 years, current or former smokers of ≥ 30 pack-years, were recruited. An annual LD CT scan was scheduled. Our algorithms considered nodules < 5 mm as negative findings and nodules > 10 mm as positive; for intermediate nodules between 5 and 10 mm, 3-month CT scan with doubling time measurement was recommended. All general practitioners, pulmonologists, and radiologists from the Somme department were solicited to participate. Subjects were selected by general practitioners or pulmonologists who checked the inclusion criteria and prescribed the CT scan.PATIENTS AND METHODSDEP KP80 was a single-arm prospective study initiated in May 2016. Participants aged 55 to 74 years, current or former smokers of ≥ 30 pack-years, were recruited. An annual LD CT scan was scheduled. Our algorithms considered nodules < 5 mm as negative findings and nodules > 10 mm as positive; for intermediate nodules between 5 and 10 mm, 3-month CT scan with doubling time measurement was recommended. All general practitioners, pulmonologists, and radiologists from the Somme department were solicited to participate. Subjects were selected by general practitioners or pulmonologists who checked the inclusion criteria and prescribed the CT scan.Over a 2.5-year period, 1307 subjects were recruited. Screening was negative in 733 cases (77.2%), positive in 54 (5.7%), and indeterminate in 162 (17.1%). After the 3-month scans, 57 subjects screened positive: 26 patients exhibited 31 lung cancers (67.7% of stage 0 to I), of whom 76.9% underwent surgical resection, and 29 had no cancer (false-positive rate = 3.1%). The prevalence of lung cancer was 2.7%.RESULTSOver a 2.5-year period, 1307 subjects were recruited. Screening was negative in 733 cases (77.2%), positive in 54 (5.7%), and indeterminate in 162 (17.1%). After the 3-month scans, 57 subjects screened positive: 26 patients exhibited 31 lung cancers (67.7% of stage 0 to I), of whom 76.9% underwent surgical resection, and 29 had no cancer (false-positive rate = 3.1%). The prevalence of lung cancer was 2.7%.This study demonstrated the feasibility of organized lung cancer screening using LD CT scan within a real-life context in the general population.CONCLUSIONThis study demonstrated the feasibility of organized lung cancer screening using LD CT scan within a real-life context in the general population.
Lung cancer mortality has been found to decrease significantly with low-dose (LD) computed tomographic (CT) screening among current or former smokers. However, such a screening program is not implemented in France. This study assessed the feasibility of a lung cancer screening program using LD CT scan in a French administrative territory. We report here the results of the first screening round. DEP KP80 was a single-arm prospective study initiated in May 2016. Participants aged 55 to 74 years, current or former smokers of ≥ 30 pack-years, were recruited. An annual LD CT scan was scheduled. Our algorithms considered nodules < 5 mm as negative findings and nodules > 10 mm as positive; for intermediate nodules between 5 and 10 mm, 3-month CT scan with doubling time measurement was recommended. All general practitioners, pulmonologists, and radiologists from the Somme department were solicited to participate. Subjects were selected by general practitioners or pulmonologists who checked the inclusion criteria and prescribed the CT scan. Over a 2.5-year period, 1307 subjects were recruited. Screening was negative in 733 cases (77.2%), positive in 54 (5.7%), and indeterminate in 162 (17.1%). After the 3-month scans, 57 subjects screened positive: 26 patients exhibited 31 lung cancers (67.7% of stage 0 to I), of whom 76.9% underwent surgical resection, and 29 had no cancer (false-positive rate = 3.1%). The prevalence of lung cancer was 2.7%. This study demonstrated the feasibility of organized lung cancer screening using LD CT scan within a real-life context in the general population.
Author Leleu, Olivier
Auquier, Marianne
Pétigny, Valérie
Milleron, Bernard
Clarot, Caroline
Chauffert, Bruno
Hoguet, Estelle
Basille, Damien
Addi, Amale Aït
Berna, Pascal
Jounieaux, Vincent
Author_xml – sequence: 1
  givenname: Olivier
  surname: Leleu
  fullname: Leleu, Olivier
  email: leleu.olivier@ch-abbeville.fr
  organization: Department of Pulmonology, Center Hospitalier d’Abbeville, Abbeville, France
– sequence: 2
  givenname: Damien
  orcidid: 0000-0001-8979-9792
  surname: Basille
  fullname: Basille, Damien
  organization: Department of Pulmonology, CHU Amiens, Amiens, France
– sequence: 3
  givenname: Marianne
  surname: Auquier
  fullname: Auquier, Marianne
  organization: Department of Radiology, CHU Amiens, Amiens, France
– sequence: 4
  givenname: Caroline
  surname: Clarot
  fullname: Clarot, Caroline
  organization: Department of Pulmonology, Center Hospitalier d’Abbeville, Abbeville, France
– sequence: 5
  givenname: Estelle
  surname: Hoguet
  fullname: Hoguet, Estelle
  organization: Department of Pulmonology, Center Hospitalier d’Abbeville, Abbeville, France
– sequence: 6
  givenname: Valérie
  surname: Pétigny
  fullname: Pétigny, Valérie
  organization: ADEMA80, Amiens, France
– sequence: 7
  givenname: Amale Aït
  surname: Addi
  fullname: Addi, Amale Aït
  organization: Department of Pulmonology, CHU Amiens, Amiens, France
– sequence: 8
  givenname: Bernard
  surname: Milleron
  fullname: Milleron, Bernard
  organization: Intergroupe francophone de cancérologie thoracique (IFCT), Paris, France
– sequence: 9
  givenname: Bruno
  surname: Chauffert
  fullname: Chauffert, Bruno
  organization: Department of Medical Oncology, CHU Amiens, Amiens, France
– sequence: 10
  givenname: Pascal
  surname: Berna
  fullname: Berna, Pascal
  organization: Department of Thoracic Surgery, CHU Amiens, Amiens, France
– sequence: 11
  givenname: Vincent
  surname: Jounieaux
  fullname: Jounieaux, Vincent
  organization: Department of Pulmonology, CHU Amiens, Amiens, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31982356$$D View this record in MEDLINE/PubMed
https://u-picardie.hal.science/hal-03591436$$DView record in HAL
BookMark eNqFkc1u1DAUhS1URH_gBVggL2GRwT-J41RsykApUiQQLQtWlse5ph489mAng-btcTSliy7Kytb1913J55yioxADIPSSkgUlVLxdL4z3ZsEI7cpgQWj9BJ3QjsuKiI4clXvDmqrlpD5GpzmvCWGCU_YMHXPaScYbcYJ-9FP4iZc6GEj42iSA4Mpgtcd9_FN9iBnw8qY86HCO3-sM3gXA3yBPfsw4WqzxZYJgbvHXFPMWzOh2gK_Hadg_R0-t9hle3J1n6Pvlx5vlVdV_-fR5edFXpq7pWFEqu1aKTkrLWysIF4wbO0haa0aHjnLQspUtFxps09RsxSy3DelIK6xmcuBn6M1h7632apvcRqe9itqpq4tezTPCm47WXOxoYV8f2G2KvyfIo9q4bMB7HSBOWTFeCyY5I21BX92h02oDw_3mf9EVgB0AU36eE9h7hBI196PWau5Hzf3Ms9JPkeQDybhRjy6GMWnnH1ffHVQoYe4cJJWNK9HD4FLJXQ3RPa6fP9BN6dIZ7X_B_n_yX5nvusI
CitedBy_id crossref_primary_10_1016_j_rmra_2020_11_009
crossref_primary_10_1093_jncics_pkae082
crossref_primary_10_1016_j_resmer_2024_101084
crossref_primary_10_1016_j_diii_2021_01_012
crossref_primary_10_1016_j_chest_2021_06_063
crossref_primary_10_1093_eurpub_ckae183
crossref_primary_10_1016_S1877_1203_21_00092_6
crossref_primary_10_1016_S1636_5410_23_47960_3
crossref_primary_10_1016_S1877_1203_23_00126_X
crossref_primary_10_1016_j_jacr_2023_02_014
crossref_primary_10_2478_pneum_2023_0045
crossref_primary_10_1016_S1877_1203_22_00098_2
crossref_primary_10_1155_2022_3585567
crossref_primary_10_1016_j_resmer_2023_100992
crossref_primary_10_1016_j_rmr_2024_03_001
crossref_primary_10_1097_CM9_0000000000002353
crossref_primary_10_1016_j_heliyon_2024_e31950
crossref_primary_10_3390_cancers15164039
crossref_primary_10_3389_fpubh_2022_938113
crossref_primary_10_1016_j_rmr_2021_02_003
crossref_primary_10_1155_2021_7897784
crossref_primary_10_1016_j_jrras_2024_100982
crossref_primary_10_1016_S1877_1203_20_30082_3
crossref_primary_10_1016_j_ctarc_2022_100561
crossref_primary_10_1016_j_cllc_2021_09_009
crossref_primary_10_1186_s12951_022_01263_6
crossref_primary_10_1016_j_jtocrr_2022_100329
crossref_primary_10_1016_j_rmra_2024_11_240
crossref_primary_10_1088_2057_1976_aca9d5
crossref_primary_10_1016_S1877_1203_24_00072_7
crossref_primary_10_1016_j_rmra_2020_11_244
crossref_primary_10_3390_cancers16233981
crossref_primary_10_3390_cancers14174089
crossref_primary_10_1016_j_resmer_2022_100887
crossref_primary_10_1016_j_bulcan_2022_11_006
crossref_primary_10_1016_j_ebiom_2024_105396
crossref_primary_10_1016_S1634_7358_23_47947_8
Cites_doi 10.1016/S0140-6736(99)06093-6
10.1097/JTO.0000000000000630
10.1097/JTO.0b013e31828f68d6
10.1093/annonc/mdz117
10.1056/NEJMoa060476
10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO;2-0
10.1016/S1470-2045(14)70387-0
10.1016/j.jtho.2015.09.009
10.1183/09031936.00033015
10.1002/ijc.32486
10.1097/JTO.0000000000000530
10.1093/ejcts/ezs081
10.1136/thoraxjnl-2017-211377
10.7326/M13-2771
10.1016/j.lungcan.2008.07.003
10.1016/j.lungcan.2007.05.009
10.1164/rccm.201505-1040OC
10.1164/rccm.201408-1475OC
10.1016/j.rmr.2016.08.003
10.1016/j.jbi.2014.02.013
10.3310/hta20400
10.1097/JTO.0b013e3181a0d98f
10.1016/S1470-2045(17)30597-1
10.1016/S1470-2045(17)30861-6
10.1503/cmaj.151421
10.1007/s00330-016-4228-3
10.1183/09031936.00197712
10.1056/NEJMoa1208962
10.1056/NEJMoa1102873
10.1056/NEJMoa0906085
10.1016/j.rmr.2015.10.004
10.1093/annonc/mds476
10.1136/thoraxjnl-2011-200736
ContentType Journal Article
Copyright 2019 Elsevier Inc.
Copyright © 2019 Elsevier Inc. All rights reserved.
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: 2019 Elsevier Inc.
– notice: Copyright © 2019 Elsevier Inc. All rights reserved.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
DOI 10.1016/j.cllc.2019.10.014
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Hyper Article en Ligne (HAL)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList


MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1938-0690
EndPage 152
ExternalDocumentID oai:HAL:hal-03591436v1
31982356
10_1016_j_cllc_2019_10_014
S1525730419302888
Genre Research Support, Non-U.S. Gov't
Multicenter Study
Journal Article
GeographicLocations France
GeographicLocations_xml – name: France
GroupedDBID ---
--K
--M
.1-
.FO
.XZ
.~1
0R~
1P~
1~.
29B
4.4
457
4G.
53G
5GY
5VS
6J9
6PF
7-5
8P~
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACLOT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEGXH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGQPQ
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
C45
CAG
COF
DU5
EBS
EFJIC
EFKBS
EFLBG
EJD
EMOBN
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
GBLVA
HVGLF
HZ~
KOM
M41
MET
MO0
O-L
O9-
OAUVE
OBH
OC~
OHH
OO-
OVD
P-8
P-9
PC.
Q38
R2-
ROL
SDF
SEL
SES
SPCBC
SSH
SSZ
T5K
TEORI
UDS
Z5R
~G-
~HD
AACTN
AAIAV
ABLVK
ABYKQ
AFCTW
AFKWA
AJBFU
AJOXV
AMFUW
EMB
LCYCR
SV3
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
ID FETCH-LOGICAL-c441t-1189786988f37f603623cfd814a21d913ea878736aef5542b2f3f509076fa28d3
IEDL.DBID .~1
ISSN 1525-7304
1938-0690
IngestDate Tue Oct 14 20:11:54 EDT 2025
Sun Sep 28 02:31:06 EDT 2025
Thu Apr 03 07:10:00 EDT 2025
Thu Apr 24 23:10:00 EDT 2025
Wed Oct 29 21:11:23 EDT 2025
Fri Feb 23 02:48:54 EST 2024
Tue Oct 14 19:31:11 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Low dose CT scan
Screening
Lung cancer
Lung nodule
Tobacco smoking
Language English
License Copyright © 2019 Elsevier Inc. All rights reserved.
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c441t-1189786988f37f603623cfd814a21d913ea878736aef5542b2f3f509076fa28d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-8979-9792
0000-0001-7533-5401
0000-0003-2856-4951
0000-0003-2131-6429
PMID 31982356
PQID 2346283207
PQPubID 23479
PageCount 8
ParticipantIDs hal_primary_oai_HAL_hal_03591436v1
proquest_miscellaneous_2346283207
pubmed_primary_31982356
crossref_primary_10_1016_j_cllc_2019_10_014
crossref_citationtrail_10_1016_j_cllc_2019_10_014
elsevier_sciencedirect_doi_10_1016_j_cllc_2019_10_014
elsevier_clinicalkey_doi_10_1016_j_cllc_2019_10_014
PublicationCentury 2000
PublicationDate 2020-03-01
PublicationDateYYYYMMDD 2020-03-01
PublicationDate_xml – month: 03
  year: 2020
  text: 2020-03-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Clinical lung cancer
PublicationTitleAlternate Clin Lung Cancer
PublicationYear 2020
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Gendarme, Perrot, Reskot (bib13) 2017; 34
de Koning (bib7) 2018
van Klaveren, Oudkerk, Prokop (bib16) 2009; 361
Infante, Cavuto, Lutman (bib22) 2015; 191
Wille, Dirksen, Ashraf (bib23) 2016; 193
Fontana, Sanderson, Woolner (bib4) 1991; 67
Hajian-Tilaki (bib14) 2014; 48
Becker, Motsch, Gross (bib24) 2015; 10
Couraud, Cortot, Greillier (bib10) 2013; 24
bib11
Pedersen, Ashraf, Dirksen (bib30) 2009; 4
(bib6) 2011; 365
Oudkerk, Devaraj, Vliegenthart (bib39) 2017; 18
Bray, Ferlay, Soerjomataram, Siegel, Torre, Jemal (bib1) 2018; 68
Goldstraw, Chansky, Crowley (bib2) 2016; 11
Lopes Pegna, Picozzi, Mascalchi (bib21) 2009; 64
Leleu, Auquier, Carre (bib12) 2017; 34
Blanchon, Bréchot, Grenier (bib27) 2007; 58
Tammemagi, Schmidt, Martel (bib33) 2017; 18
Kauczor, Bonomo, Gaga (bib20) 2015; 46
Pastorino, Silva, Sestini (bib8) 2019; 30
Henschke, McCauley, Yankelevitz (bib5) 1999; 354
Travis, Brambilla, Nicholson (bib17) 2015; 10
Pegna, Picozzi, Falaschi (bib32) 2013; 8
(bib19) 2016; 188
Sverzellati, Silva, Calareso (bib38) 2016; 26
Saghir, Dirksen, Ashraf (bib31) 2012; 67
Horeweg, Scholten, de Jong (bib15) 2014; 15
bib25
Henschke, Yankelevitz (bib3) 2006; 355
Becker N, Motsch E, Trotter A, et al. Lung cancer mortality reduction by LDCT screening: results from the randomized German LUSI trial [e-pub ahead of print]. Int J Cancer.
bib26
Van’t Westeinde, Horeweg, De Leyn (bib35) 2012; 42
.
Crosbie, Balata, Evison (bib34) 2019; 74
Horeweg, van der Aalst, Vliegenthart (bib28) 2013; 42
Moyer (bib18) 2014; 160
Aberle, DeMello, Berg (bib29) 2013; 369
Brouchet (bib36) 2011; 3
Field, Duffy, Baldwin (bib37) 2016; 20
de Koning (10.1016/j.cllc.2019.10.014_bib7) 2018
Horeweg (10.1016/j.cllc.2019.10.014_bib28) 2013; 42
Travis (10.1016/j.cllc.2019.10.014_bib17) 2015; 10
Kauczor (10.1016/j.cllc.2019.10.014_bib20) 2015; 46
Lopes Pegna (10.1016/j.cllc.2019.10.014_bib21) 2009; 64
Wille (10.1016/j.cllc.2019.10.014_bib23) 2016; 193
Brouchet (10.1016/j.cllc.2019.10.014_bib36) 2011; 3
Moyer (10.1016/j.cllc.2019.10.014_bib18) 2014; 160
Blanchon (10.1016/j.cllc.2019.10.014_bib27) 2007; 58
van Klaveren (10.1016/j.cllc.2019.10.014_bib16) 2009; 361
Aberle (10.1016/j.cllc.2019.10.014_bib29) 2013; 369
10.1016/j.cllc.2019.10.014_bib9
Henschke (10.1016/j.cllc.2019.10.014_bib3) 2006; 355
Tammemagi (10.1016/j.cllc.2019.10.014_bib33) 2017; 18
(10.1016/j.cllc.2019.10.014_bib19) 2016; 188
Oudkerk (10.1016/j.cllc.2019.10.014_bib39) 2017; 18
Goldstraw (10.1016/j.cllc.2019.10.014_bib2) 2016; 11
Saghir (10.1016/j.cllc.2019.10.014_bib31) 2012; 67
Pastorino (10.1016/j.cllc.2019.10.014_bib8) 2019; 30
Bray (10.1016/j.cllc.2019.10.014_bib1) 2018; 68
Pedersen (10.1016/j.cllc.2019.10.014_bib30) 2009; 4
Sverzellati (10.1016/j.cllc.2019.10.014_bib38) 2016; 26
Van’t Westeinde (10.1016/j.cllc.2019.10.014_bib35) 2012; 42
Crosbie (10.1016/j.cllc.2019.10.014_bib34) 2019; 74
Gendarme (10.1016/j.cllc.2019.10.014_bib13) 2017; 34
Infante (10.1016/j.cllc.2019.10.014_bib22) 2015; 191
Field (10.1016/j.cllc.2019.10.014_bib37) 2016; 20
Pegna (10.1016/j.cllc.2019.10.014_bib32) 2013; 8
Fontana (10.1016/j.cllc.2019.10.014_bib4) 1991; 67
Hajian-Tilaki (10.1016/j.cllc.2019.10.014_bib14) 2014; 48
Becker (10.1016/j.cllc.2019.10.014_bib24) 2015; 10
Henschke (10.1016/j.cllc.2019.10.014_bib5) 1999; 354
(10.1016/j.cllc.2019.10.014_bib6) 2011; 365
Couraud (10.1016/j.cllc.2019.10.014_bib10) 2013; 24
Horeweg (10.1016/j.cllc.2019.10.014_bib15) 2014; 15
Leleu (10.1016/j.cllc.2019.10.014_bib12) 2017; 34
References_xml – volume: 26
  start-page: 3821
  year: 2016
  end-page: 3829
  ident: bib38
  article-title: Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen
  publication-title: Eur Radiol
– volume: 4
  start-page: 608
  year: 2009
  end-page: 614
  ident: bib30
  article-title: The Danish randomized lung cancer CT screening trial—overall design and results of the prevalence round
  publication-title: J Thorac Oncol
– volume: 3
  start-page: 326
  year: 2011
  end-page: 330
  ident: bib36
  article-title: Critères de qualité en chirurgie thoracique oncologique. Impact sur la lecture des essais cliniques
  publication-title: Rev Mal Respir Actual
– volume: 18
  start-page: e754
  year: 2017
  end-page: e766
  ident: bib39
  article-title: European position statement on lung cancer screening
  publication-title: Lancet Oncol
– volume: 10
  start-page: 890
  year: 2015
  end-page: 896
  ident: bib24
  article-title: Randomized study on early detection of lung cancer with MSCT in Germany: results of the first 3 years of follow-up after randomization
  publication-title: J Thorac Oncol
– volume: 20
  start-page: 1
  year: 2016
  end-page: 146
  ident: bib37
  article-title: The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer
  publication-title: Health Technol Assess
– volume: 46
  start-page: 28
  year: 2015
  end-page: 39
  ident: bib20
  article-title: ESR/ERS white paper on lung cancer screening
  publication-title: Eur Respir J
– volume: 8
  start-page: 866
  year: 2013
  end-page: 875
  ident: bib32
  article-title: Four-year results of low-dose CT screening and nodule management in the ITALUNG trial
  publication-title: J Thorac Oncol
– ident: bib11
  article-title: Pertinence du dépistage du cancer broncho-pulmonaire en France: point de situation sur les données disponibles: analyse critique des études contrôlées randomisées
– volume: 160
  start-page: 330
  year: 2014
  end-page: 338
  ident: bib18
  article-title: Screening for lung cancer: US Preventive Services Task Force recommendation statement
  publication-title: Ann Intern Med
– start-page: 23
  year: 2018
  end-page: 26
  ident: bib7
  article-title: Effect of volume CT lung cancer screening: mortality results of the Nelson randomised controlled population based trial [abstract PL02.05]. Paper presented at: 19th World Conference on Lung Cancer; Toronto, Ontario, Canada; September
– volume: 188
  start-page: 425
  year: 2016
  end-page: 432
  ident: bib19
  article-title: Recommendations on screening for lung cancer
  publication-title: CMAJ
– volume: 34
  start-page: 262
  year: 2017
  end-page: 267
  ident: bib12
  article-title: Dépistage des cancers bronchopulmonaires par tomodensitométrie thoracique à faible dose dans la Somme
  publication-title: Rev Mal Respir
– volume: 354
  start-page: 99
  year: 1999
  end-page: 105
  ident: bib5
  article-title: Early Lung Cancer Action Project: overall design and findings from baseline screening
  publication-title: Lancet
– volume: 24
  start-page: 586
  year: 2013
  end-page: 597
  ident: bib10
  article-title: From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French Intergroup (IFCT) and the Groupe d’Oncologie de Langue Francaise (GOLF)
  publication-title: Ann Oncol
– volume: 10
  start-page: 1243
  year: 2015
  end-page: 1260
  ident: bib17
  article-title: 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification
  publication-title: J Thorac Oncol
– volume: 67
  start-page: 296
  year: 2012
  end-page: 301
  ident: bib31
  article-title: CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT
  publication-title: Thorax
– ident: bib25
  article-title: Taux de participation au programme de dépistage organisé du cancer colorectal, 2016-2017. Indicateurs d’évaluation. Evaluation du programme de dépistage du cancer colorectal. Evaluation des programmes de dépistage des cancers. Cancers. Maladies chroniques et traumatismes. Dossiers thématiques
– volume: 34
  start-page: 717
  year: 2017
  end-page: 728
  ident: bib13
  article-title: [Economic impact of lung cancer screening in France: a modeling study]
  publication-title: Rev Mal Respir
– volume: 58
  start-page: 50
  year: 2007
  end-page: 58
  ident: bib27
  article-title: Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR)
  publication-title: Lung Cancer
– volume: 193
  start-page: 542
  year: 2016
  end-page: 551
  ident: bib23
  article-title: Results of the randomized Danish Lung Cancer Screening Trial with focus on high-risk profiling
  publication-title: Am J Respir Crit Care Med
– volume: 355
  start-page: 1763
  year: 2006
  end-page: 1771
  ident: bib3
  article-title: Survival of patients with stage I lung cancer detected on CT screening
  publication-title: N Engl J Med
– volume: 30
  start-page: 1162
  year: 2019
  end-page: 1169
  ident: bib8
  article-title: Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
  publication-title: Ann Oncol
– volume: 191
  start-page: 1166
  year: 2015
  end-page: 1175
  ident: bib22
  article-title: Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography
  publication-title: Am J Respir Crit Care Med
– volume: 15
  start-page: 1342
  year: 2014
  end-page: 1350
  ident: bib15
  article-title: Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers
  publication-title: Lancet Oncol
– volume: 365
  start-page: 395
  year: 2011
  end-page: 409
  ident: bib6
  article-title: Reduced lung-cancer mortality with low-dose computed tomographic screening
  publication-title: N Engl J Med
– volume: 48
  start-page: 193
  year: 2014
  end-page: 204
  ident: bib14
  article-title: Sample size estimation in diagnostic test studies of biomedical informatics
  publication-title: J Biomed Inform
– volume: 67
  start-page: 1155
  year: 1991
  end-page: 1164
  ident: bib4
  article-title: Screening for lung cancer. A critique of the Mayo Lung Project
  publication-title: Cancer
– volume: 18
  start-page: 1523
  year: 2017
  end-page: 1531
  ident: bib33
  article-title: Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study
  publication-title: Lancet Oncol
– reference: .
– volume: 74
  start-page: 405
  year: 2019
  end-page: 409
  ident: bib34
  article-title: Implementing lung cancer screening: baseline results from a community-based “Lung Health Check” pilot in deprived areas of Manchester
  publication-title: Thorax
– ident: bib26
  article-title: Taux de participation au programme de dépistage organisé du cancer du sein, 2015-2016. Indicateurs d’évaluation. Evaluation du programme de dépistage du cancer du sein. Evaluation des programmes de dépistage des cancers. Cancers. Maladies chroniques et traumatismes. Dossiers thématiques
– volume: 42
  start-page: 1659
  year: 2013
  end-page: 1667
  ident: bib28
  article-title: Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial
  publication-title: Eur Respir J
– reference: Becker N, Motsch E, Trotter A, et al. Lung cancer mortality reduction by LDCT screening: results from the randomized German LUSI trial [e-pub ahead of print]. Int J Cancer.
– volume: 361
  start-page: 2221
  year: 2009
  end-page: 2229
  ident: bib16
  article-title: Management of lung nodules detected by volume CT scanning
  publication-title: N Engl J Med
– volume: 68
  start-page: 394
  year: 2018
  end-page: 424
  ident: bib1
  article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
– volume: 11
  start-page: 39
  year: 2016
  end-page: 51
  ident: bib2
  article-title: The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer
  publication-title: J Thorac Oncol
– volume: 64
  start-page: 34
  year: 2009
  end-page: 40
  ident: bib21
  article-title: Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT
  publication-title: Lung Cancer
– volume: 42
  start-page: 420
  year: 2012
  end-page: 429
  ident: bib35
  article-title: Complications following lung surgery in the Dutch–Belgian randomized lung cancer screening trial
  publication-title: Eur J Cardiothorac Surg
– volume: 369
  start-page: 920
  year: 2013
  end-page: 931
  ident: bib29
  article-title: Results of the two incidence screenings in the National Lung Screening Trial
  publication-title: N Engl J Med
– volume: 354
  start-page: 99
  year: 1999
  ident: 10.1016/j.cllc.2019.10.014_bib5
  article-title: Early Lung Cancer Action Project: overall design and findings from baseline screening
  publication-title: Lancet
  doi: 10.1016/S0140-6736(99)06093-6
– volume: 10
  start-page: 1243
  year: 2015
  ident: 10.1016/j.cllc.2019.10.014_bib17
  article-title: 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0000000000000630
– volume: 8
  start-page: 866
  year: 2013
  ident: 10.1016/j.cllc.2019.10.014_bib32
  article-title: Four-year results of low-dose CT screening and nodule management in the ITALUNG trial
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e31828f68d6
– volume: 30
  start-page: 1162
  year: 2019
  ident: 10.1016/j.cllc.2019.10.014_bib8
  article-title: Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdz117
– volume: 355
  start-page: 1763
  year: 2006
  ident: 10.1016/j.cllc.2019.10.014_bib3
  article-title: Survival of patients with stage I lung cancer detected on CT screening
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa060476
– volume: 67
  start-page: 1155
  issue: 4 suppl
  year: 1991
  ident: 10.1016/j.cllc.2019.10.014_bib4
  article-title: Screening for lung cancer. A critique of the Mayo Lung Project
  publication-title: Cancer
  doi: 10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO;2-0
– volume: 15
  start-page: 1342
  year: 2014
  ident: 10.1016/j.cllc.2019.10.014_bib15
  article-title: Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(14)70387-0
– volume: 11
  start-page: 39
  year: 2016
  ident: 10.1016/j.cllc.2019.10.014_bib2
  article-title: The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2015.09.009
– volume: 46
  start-page: 28
  year: 2015
  ident: 10.1016/j.cllc.2019.10.014_bib20
  article-title: ESR/ERS white paper on lung cancer screening
  publication-title: Eur Respir J
  doi: 10.1183/09031936.00033015
– ident: 10.1016/j.cllc.2019.10.014_bib9
  doi: 10.1002/ijc.32486
– volume: 10
  start-page: 890
  year: 2015
  ident: 10.1016/j.cllc.2019.10.014_bib24
  article-title: Randomized study on early detection of lung cancer with MSCT in Germany: results of the first 3 years of follow-up after randomization
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0000000000000530
– volume: 42
  start-page: 420
  year: 2012
  ident: 10.1016/j.cllc.2019.10.014_bib35
  article-title: Complications following lung surgery in the Dutch–Belgian randomized lung cancer screening trial
  publication-title: Eur J Cardiothorac Surg
  doi: 10.1093/ejcts/ezs081
– volume: 68
  start-page: 394
  year: 2018
  ident: 10.1016/j.cllc.2019.10.014_bib1
  article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
– volume: 74
  start-page: 405
  year: 2019
  ident: 10.1016/j.cllc.2019.10.014_bib34
  article-title: Implementing lung cancer screening: baseline results from a community-based “Lung Health Check” pilot in deprived areas of Manchester
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2017-211377
– volume: 160
  start-page: 330
  year: 2014
  ident: 10.1016/j.cllc.2019.10.014_bib18
  article-title: Screening for lung cancer: US Preventive Services Task Force recommendation statement
  publication-title: Ann Intern Med
  doi: 10.7326/M13-2771
– volume: 64
  start-page: 34
  year: 2009
  ident: 10.1016/j.cllc.2019.10.014_bib21
  article-title: Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2008.07.003
– volume: 58
  start-page: 50
  year: 2007
  ident: 10.1016/j.cllc.2019.10.014_bib27
  article-title: Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR)
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2007.05.009
– volume: 193
  start-page: 542
  year: 2016
  ident: 10.1016/j.cllc.2019.10.014_bib23
  article-title: Results of the randomized Danish Lung Cancer Screening Trial with focus on high-risk profiling
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201505-1040OC
– volume: 191
  start-page: 1166
  year: 2015
  ident: 10.1016/j.cllc.2019.10.014_bib22
  article-title: Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201408-1475OC
– volume: 34
  start-page: 262
  year: 2017
  ident: 10.1016/j.cllc.2019.10.014_bib12
  article-title: Dépistage des cancers bronchopulmonaires par tomodensitométrie thoracique à faible dose dans la Somme
  publication-title: Rev Mal Respir
  doi: 10.1016/j.rmr.2016.08.003
– volume: 48
  start-page: 193
  year: 2014
  ident: 10.1016/j.cllc.2019.10.014_bib14
  article-title: Sample size estimation in diagnostic test studies of biomedical informatics
  publication-title: J Biomed Inform
  doi: 10.1016/j.jbi.2014.02.013
– volume: 20
  start-page: 1
  year: 2016
  ident: 10.1016/j.cllc.2019.10.014_bib37
  article-title: The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer
  publication-title: Health Technol Assess
  doi: 10.3310/hta20400
– volume: 4
  start-page: 608
  year: 2009
  ident: 10.1016/j.cllc.2019.10.014_bib30
  article-title: The Danish randomized lung cancer CT screening trial—overall design and results of the prevalence round
  publication-title: J Thorac Oncol
  doi: 10.1097/JTO.0b013e3181a0d98f
– volume: 18
  start-page: 1523
  year: 2017
  ident: 10.1016/j.cllc.2019.10.014_bib33
  article-title: Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(17)30597-1
– volume: 18
  start-page: e754
  year: 2017
  ident: 10.1016/j.cllc.2019.10.014_bib39
  article-title: European position statement on lung cancer screening
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(17)30861-6
– volume: 188
  start-page: 425
  year: 2016
  ident: 10.1016/j.cllc.2019.10.014_bib19
  article-title: Recommendations on screening for lung cancer
  publication-title: CMAJ
  doi: 10.1503/cmaj.151421
– volume: 26
  start-page: 3821
  year: 2016
  ident: 10.1016/j.cllc.2019.10.014_bib38
  article-title: Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen
  publication-title: Eur Radiol
  doi: 10.1007/s00330-016-4228-3
– volume: 42
  start-page: 1659
  year: 2013
  ident: 10.1016/j.cllc.2019.10.014_bib28
  article-title: Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial
  publication-title: Eur Respir J
  doi: 10.1183/09031936.00197712
– start-page: 23
  year: 2018
  ident: 10.1016/j.cllc.2019.10.014_bib7
– volume: 3
  start-page: 326
  year: 2011
  ident: 10.1016/j.cllc.2019.10.014_bib36
  article-title: Critères de qualité en chirurgie thoracique oncologique. Impact sur la lecture des essais cliniques
  publication-title: Rev Mal Respir Actual
– volume: 369
  start-page: 920
  year: 2013
  ident: 10.1016/j.cllc.2019.10.014_bib29
  article-title: Results of the two incidence screenings in the National Lung Screening Trial
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1208962
– volume: 365
  start-page: 395
  year: 2011
  ident: 10.1016/j.cllc.2019.10.014_bib6
  article-title: Reduced lung-cancer mortality with low-dose computed tomographic screening
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1102873
– volume: 361
  start-page: 2221
  year: 2009
  ident: 10.1016/j.cllc.2019.10.014_bib16
  article-title: Management of lung nodules detected by volume CT scanning
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0906085
– volume: 34
  start-page: 717
  year: 2017
  ident: 10.1016/j.cllc.2019.10.014_bib13
  article-title: [Economic impact of lung cancer screening in France: a modeling study]
  publication-title: Rev Mal Respir
  doi: 10.1016/j.rmr.2015.10.004
– volume: 24
  start-page: 586
  year: 2013
  ident: 10.1016/j.cllc.2019.10.014_bib10
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mds476
– volume: 67
  start-page: 296
  year: 2012
  ident: 10.1016/j.cllc.2019.10.014_bib31
  article-title: CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2011-200736
SSID ssj0026312
Score 2.37049
Snippet Lung cancer mortality has been found to decrease significantly with low-dose (LD) computed tomographic (CT) screening among current or former smokers. However,...
Two large randomized controlled trials (NLST, NELSON) revealed a significant decrease in lung cancer mortality with low-dose computed tomographic screening,...
SourceID hal
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 145
SubjectTerms Adenocarcinoma of Lung - diagnosis
Adenocarcinoma of Lung - diagnostic imaging
Adenocarcinoma of Lung - epidemiology
Aged
Algorithms
Early Detection of Cancer - methods
Female
Follow-Up Studies
France - epidemiology
Humans
Life Sciences
Low dose CT scan
Lung cancer
Lung Neoplasms - diagnosis
Lung Neoplasms - diagnostic imaging
Lung Neoplasms - epidemiology
Lung nodule
Male
Middle Aged
Prognosis
Prospective Studies
Screening
Tobacco smoking
Tomography, X-Ray Computed - methods
Title Lung Cancer Screening by Low-Dose CT Scan: Baseline Results of a French Prospective Study
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1525730419302888
https://dx.doi.org/10.1016/j.cllc.2019.10.014
https://www.ncbi.nlm.nih.gov/pubmed/31982356
https://www.proquest.com/docview/2346283207
https://u-picardie.hal.science/hal-03591436
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1938-0690
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0026312
  issn: 1525-7304
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Complete Freedom Collection [SCCMFC]
  customDbUrl:
  eissn: 1938-0690
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0026312
  issn: 1525-7304
  databaseCode: ACRLP
  dateStart: 19990801
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Science Direct
  customDbUrl:
  eissn: 1938-0690
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0026312
  issn: 1525-7304
  databaseCode: .~1
  dateStart: 19990801
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: ScienceDirect Freedom Collection
  customDbUrl:
  eissn: 1938-0690
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0026312
  issn: 1525-7304
  databaseCode: AIKHN
  dateStart: 19990801
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1938-0690
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0026312
  issn: 1525-7304
  databaseCode: AKRWK
  dateStart: 20000401
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEBZJCiWX0jZ9uI-ghtzKxruSVtb25ro1bu2EkAdNT0JaSTjF7AY_WnLpb-_MvqCHpNDTglYSYjSa-YS-mSHkEHywjVXmojyzPhJp4BHWtoqcMIl1ATyaxXjn4xM5uRRfr9KrLTJqY2GQVtnY_tqmV9a6aek30uzfXF_3z7FyD-inAAgCUyoM-BVigFUMjn53NA8mef3imWLZVujdBM7UHK98scA0hkl2hAyvRNzlnLbnyJK8C4JWrmj8mDxqMCQd1st8QrZ88ZQ8PG5eyffI9xmcYDrC_VzS8xyZNeCgqL2ls_JX9KlceTq6gB-m-EA_mioi3dMzv9os1itaBmroGGMA5_R0WbaRmBQJh7fPyOX488VoEjUlFKIccM46gusDXBNlplTggyDRXfE8OJUIwxKXJdwbBUeWS-MDAAtmWeABMEQ8kMEw5fhzslOUhX9JqItzbwHkhpQ5wePcBOm5scIbo5xzvEeSVnY6b_KLY5mLhW6JZD80ylujvLEN5N0j77sxN3V2jXt783ZLdBs3CpZOg_G_d1TajfpLs_457gB2vVsWpuGeDGca2zDtIeBM-TPpkXetUmg4l_jYYgpfblaacYz65Swe9MiLWlu6ucDsKcZT-eo_l_aa7DK89ldUuDdkZ73c-LeAjdZ2v1L-ffJg-GU6OcHv9Ozb9A9CpwtX
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaIgEXxLMsUDCIG0o3sR2vw61dWC2QrRDdSuVk2bGtFq2Sah-gXvjtnclL6qFF4up4LGtsz3yOv5kh5D34YBurzEVFZn0k0sAjrG0VOWES6wJ4NIvxzrMjOT0RX0_T0y0y7mJhkFbZ2v7GptfWum0ZttocXpyfD4-xcg_sTwEQBIZUapvcESkb4Q1s_2_P82CSN0-eKdZthe5t5ExD8ioWC8xjmGT7SPFKxE3eafsMaZI3YdDaF00ekgctiKQHzTwfkS1fPiZ3Z-0z-RPyM4cjTMe4oEt6XCC1BjwUtZc0r_5En6qVp-M5fDDlR3po6pB0T3_41WaxXtEqUEMnGAR4Rr8vqy4UkyLj8PIpOZl8no-nUVtDISoA6KwjuD_APVFmSgU-ChL9FS-CU4kwLHFZwr1RcGa5ND4AsmCWBR4ARMQjGQxTjj8jO2VV-ueEurjwFlBuSJkTPC5MkJ4bK7wxyjnHByTpdKeLNsE41rlY6I5J9kujvjXqG9tA3wPyoZe5aNJr3Nqbd0uiu8BRMHUarP-tUmkvdW1r_VPuHax6Py3Mwz09yDW2Yd5DAJrydzIgb7tNoeFg4muLKX21WWnGMeyXs3g0ILvNbunHArunGE_li_-c2htybzqf5Tr_cvTtJbnP8B9AzYt7RXbWy43fA6C0tq_rg3AF_ugLSQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lung+Cancer+Screening+by+Low-Dose+CT+Scan%3A+Baseline+Results+of+a+French+Prospective+Study&rft.jtitle=Clinical+lung+cancer&rft.au=Leleu%2C+Olivier&rft.au=Basille%2C+Damien&rft.au=Auquier%2C+Marianne&rft.au=Clarot%2C+Caroline&rft.date=2020-03-01&rft.issn=1525-7304&rft.volume=21&rft.issue=2&rft.spage=145&rft.epage=152&rft_id=info:doi/10.1016%2Fj.cllc.2019.10.014&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_cllc_2019_10_014
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1525-7304&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1525-7304&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1525-7304&client=summon